Live Chat ×
Skip to main content

Gene therapy: Bioanalytical support and strategies

Thank you

This live web event has ended. Thank you for attending.


  • Robert Dodge, Ph.D.

    Rob Dodge has worked in the Pharmaceutical Industry for over 20 years in both CMC manufacturing and analytical release of Biologic therapeutics and regulated Bioanalytical testing of small molecules, protein drugs, biomarkers and novel molecular entities such as nucleic acids, cell therapy, and gene therapy products. Rob is the Director of Bioanalytical Sciences Development, leading a team of scientists who develop bioanalytical assays to support regulated bioanalysis for pharmacodynamics and immunogenicity assessments.  Rob is currently the Discovery Bioanalytical Global Lead at Novartis supporting assay development and bioanalytical testing using LC/MS/MS, LBA, qPCR, flow cytometry and cell based bioanalytical platforms for small molecules, biologics, nucleic acids and gene therapy therapeutics.

May 9, 2019
Thu 12:30 PM EDT

Duration 1H 30M

This live web event has ended.